Rheb/mTOR activation and regulation in cancer: novel treatment strategies beyond rapamycin.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Drug Targets

• Publication date

  2011-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138945011795906589PMID 21561413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors

  2010cited by this paper
• Selective autophagy in cancer development and therapy.

  2010cited by this paper
• A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer

  2010cited by this paper
• ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

  2010cited by this paper
• Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.

  2010cited by this paper
• Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.

  2010cited by this paper
• Drugging the PI3 kinome: from chemical tools to drugs in the clinic.

  2010cited by this paper
• Glycolytic Flux Signals to mTOR through Glyceraldehyde-3-Phosphate Dehydrogenase-Mediated Regulation of Rheb

  2009cited by this paper
• Effect of autophagy on multiple myeloma cell viability

  2009cited by this paper
• Renal and liver tumors in Tsc2+/− mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

  2009cited by this paper
• mTORC1 Phosphorylates the ULK1-mAtg13-FIP200 Autophagy Regulatory Complex

  2009cited by this paper
• Tubers and tumors: rapamycin therapy for benign and malignant tumors.

  2009cited by this paper
• Tuberous Sclerosis Complex Activity Is Required to Control Neuronal Stress Responses in an mTOR-Dependent Manner

  2009cited by this paper
• Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.

  2009cited by this paper
• Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

  2009cited by this paper
• Differential Requirement of CAAX-mediated Posttranslational Processing for Rheb Localization and Signaling

  2009cited by this paper
• mTOR signaling at a glance

  2009cited by this paper
• An emerging role of mTOR in lipid biosynthesis.

  2009cited by this paper
• Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy.

  2009cited by this paper
• mTOR and cancer: many loops in one pathway.

  2009cited by this paper
• ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy*

  2009cited by this paper
• Molecular mechanisms of mTOR-mediated translational control

  2009cited by this paper
• An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1*

  2009cited by this paper
• DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

  2009cited by this paper
• GCN2 Protein Kinase Is Required to Activate Amino Acid Deprivation Responses in Mice Treated with the Anti-cancer Agent l-Asparaginase*

  2009cited by this paper
• Rheb controls misfolded protein metabolism by inhibiting aggresome formation and autophagy

  2009cited by this paper
• mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.

  2009cited by this paper
• Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.

  2009cited by this paper
• AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.

  2008cited by this paper
• Regulation of TORC1 by Rag GTPases in nutrient response

  2008cited by this paper
• AMPK phosphorylation of raptor mediates a metabolic checkpoint.

  2008cited by this paper
• Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling

  2008cited by this paper
• WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase.

  2008cited by this paper
• Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis.

  2008cited by this paper
• mTOR is activated in the majority of malignant melanomas.

  2008cited by this paper
• Growth stimulation leads to cellular senescence when the cell cycle is blocked

  2008cited by this paper
• Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34.

  2008cited by this paper
• Autophagy in the pathogenesis of disease.

  2008cited by this paper
• E3 ubiquitin ligase E6AP‐mediated TSC2 turnover in the presence and absence of HPV16 E6

  2008cited by this paper
• The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1

  2008cited by this paper
• Tumorigenic activity and therapeutic inhibition of Rheb GTPase.

  2008cited by this paper
• The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C

  2008cited by this paper
• FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression

  2008cited by this paper
• The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2

  2008cited by this paper
• mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation.

  2008cited by this paper
• Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation

  2008cited by this paper
• SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth

  2008cited by this paper
• PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.

  2007cited by this paper
• mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex

  2007cited by this paper
• Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53

  2007cited by this paper
• AKT/PKB signaling: navigating downstream.

  2007cited by this paper
• Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

  2007cited by this paper
• Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.

  2007cited by this paper
• The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes.

  2007cited by this paper
• PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding*

  2007cited by this paper
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

  2007cited by this paper
• Bnip3 Mediates the Hypoxia-induced Inhibition on Mammalian Target of Rapamycin by Interacting with Rheb*

  2007cited by this paper
• TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

  2006cited by this paper
• Biological correlates of p27 compartmental expression in prostate cancer.

  2006cited by this paper
• Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.

  2006cited by this paper
• Lipid posttranslational modifications. Farnesyl transferase inhibitors.

  2006cited by this paper
• Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.

  2006cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.

  2006cited by this paper
• PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.

  2006cited by this paper
• Loss of autophagy in the central nervous system causes neurodegeneration in mice

  2006cited by this paper
• Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling

  2005cited by this paper
• Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase.

  2005cited by this paper
• Differential Membrane Localization of ERas and Rheb, Two Ras-related Proteins Involved in the Phosphatidylinositol 3-Kinase/mTOR Pathway*

  2005cited by this paper
• SKAR is a specific target of S6 kinase 1 in cell growth control.

  2004cited by this paper
• The Rheb family of GTP-binding proteins.

  2004cited by this paper
• Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.

  2004cited by this paper
• Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.

  2004cited by this paper
• Pam and Its Ortholog Highwire Interact with and May Negatively Regulate the TSC1·TSC2 Complex*

  2004cited by this paper
• Phosphorylation of the Eukaryotic Translation Initiation Factor eIF4E Contributes to Its Transformation and mRNA Transport Activities

  2004cited by this paper
• Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases

  2004cited by this paper
• Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

  2004cited by this paper
• Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

  2003cited by this paper
• Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

  2003cited by this paper
• Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner*

  2003cited by this paper
• TSC2 mediates cellular energy response to control cell growth and survival.

  2003cited by this paper
• Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer

  2003cited by this paper
• Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.

  2003cited by this paper
• Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.

  2003cited by this paper
• Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.

  2003cited by this paper
• The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation

  2003cited by this paper
• Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

  2002cited by this paper
• Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin

  2002cited by this paper
• Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.

  2002cited by this paper
• TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

  2002cited by this paper
• A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.

  2002cited by this paper
• Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling

  2002cited by this paper
• The Immunosuppressant Rapamycin Mimics a Starvation-Like Signal Distinct from Amino Acid and Glucose Deprivation

  2002cited by this paper
• Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals.

  2001cited by this paper
• The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination

  2000cited by this paper

• A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice

  2023cites this paper
• Therapies modulating insulin resistance in Parkinson's disease: A cross talk.

  2021cites this paper
• Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis.

  2020cites this paper
• Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway

  2020cites this paper
• Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes

  2019cites this paper
• mTOR signalling: jack-of-all-trades 1.

  2019cites this paper
• Apelin-36 exerts the cytoprotective effect against MPP+-induced cytotoxicity in SH-SY5Y cells through PI3K/Akt/mTOR autophagy pathway.

  2019cites this paper
• Identifying RHEB as a metastatic driver in clear-cell renal cell carcinoma through bioinformatics analysis

  2017cites this paper
• Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges.

  2015cites this paper
• Rheb phosphorylation is involved in p38-regulated/activated protein kinase-mediated tumor suppression in liver cancer.

  2015cites this paper
• mTOR regulates Aurora A via enhancing protein stability

  2014cites this paper
• Ursolic Acid Inhibits Leucine-Stimulated mTORC1 Signaling by Suppressing mTOR Localization to Lysosome

  2014cites this paper
• Pathological and molecular advances in pediatric low-grade astrocytoma.

  2013cites this paper
• Therapeutic agents triggering nonapoptotic cancer cell death.

  2013cites this paper
• Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress.

  2012cites this paper
• Rheb is a Critical Regulator of Autophagy During Myocardial Ischemia: Pathophysiological Implications in Obesity and Metabolic Syndrome

  2012cites this paper
• Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer

  2012cites this paper
• Autophagy-regulating small molecules and their therapeutic applications.

  2012cites this paper
• MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer

  2012cites this paper
• Two-compartment tumor metabolism

  2012cites this paper
• High throughput screening for drug discovery of autophagy modulators.

  2012cites this paper
• The tumor suppressing roles of tissue structure in cervical cancer development

  2012cites this paper
• Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer

  2012cites this paper
• Farnesyltransferase Inhibitor in Cancer Treatment

  2011cites this paper
• Two-compartment tumor metabolism: autophagy in the tumor Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. (OXPHOS) in cancer cells.

  year unknowncites this paper